BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3086541)

  • 1. Distribution and metabolism of nitroglycerin and its metabolites in vascular beds of sheep.
    Cossum PA; Roberts MS; Yong AC; Kilpatrick D
    J Pharmacol Exp Ther; 1986 Jun; 237(3):959-66. PubMed ID: 3086541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood vessel uptake and metabolism of organic nitrates in the rat.
    Fung HL; Sutton SC; Kamiya A
    J Pharmacol Exp Ther; 1984 Feb; 228(2):334-41. PubMed ID: 6420543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of nitroglycerin on intestinal vascular capacitance and conductance.
    Chihara E; Manyari DE; Isaac DL; Tyberg JV
    Can J Cardiol; 2002 Feb; 18(2):165-74. PubMed ID: 11875586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of intravenous nitroglycerin: importance of the delivery system.
    Mutch WA; Culligan JD; Cote DD; Thomson IR
    Anesth Analg; 1982 Nov; 61(11):927-32. PubMed ID: 6814298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion.
    Sage PR; de la Lande IS; Stafford I; Bennett CL; Phillipov G; Stubberfield J; Horowitz JD
    Circulation; 2000 Dec; 102(23):2810-5. PubMed ID: 11104737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular and hemodynamic differences between organic nitrates and nitrites.
    Bauer JA; Nolan T; Fung HL
    J Pharmacol Exp Ther; 1997 Jan; 280(1):326-31. PubMed ID: 8996213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers.
    Dudenhoefer AA; Loureiro-Silva MR; Cadelina GW; Gupta T; Groszmann RJ
    Hepatology; 2002 Aug; 36(2):381-5. PubMed ID: 12143046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.
    Fung HL; Blei A; Chong S
    J Pharmacol Exp Ther; 1986 Dec; 239(3):701-5. PubMed ID: 3098960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the liver in the disposition of intravenous nitroglycerin in the rat.
    Blei AT; Gottstein J; Fung HL
    Biochem Pharmacol; 1984 Aug; 33(16):2681-6. PubMed ID: 6431989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivation of nitroglycerin to nitric oxide (NO) and S-nitrosothiols in the rat liver and evaluation of the coexisting hypotensive effect.
    Sokołowska M; Bednarski M; Kwiecień I; Filipek B; Włodek L
    Fundam Clin Pharmacol; 2004 Aug; 18(4):449-56. PubMed ID: 15312151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dosage regimen on the development of tolerance to nitroglycerin in rats.
    Sutton SC; Fung HL
    J Cardiovasc Pharmacol; 1983; 5(6):1086-92. PubMed ID: 6196559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of nitroglycerin on the resistance, exchange and capacitance functions of the canine intestinal vasculature.
    Chen HI; Yeh FC; Ho W
    J Pharmacol Exp Ther; 1981 Aug; 218(2):497-503. PubMed ID: 6788937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
    Kazeĭ DV; Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):27-34. PubMed ID: 3148308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests.
    Jneid H; Chandra M; Alshaher M; Hornung CA; Tang XL; Leesar M; Bolli R
    Circulation; 2005 May; 111(20):2565-71. PubMed ID: 15897341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrahepatic metabolism and distribution of aspirin in vascular beds of sheep.
    Cossum PA; Roberts MS; Kilpatrick D; Yong AC
    J Pharm Sci; 1986 Aug; 75(8):731-7. PubMed ID: 3772743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.